Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the...
4 insider purchases on record · latest filing 2025-03-19.
Insiders have also filed 30 sale transactions at IMCR.